CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 77 filers reported holding CYTOSORBENTS CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $265,000 | +8.6% | 37,615 | 0.0% | 1.61% | +5.0% |
| Q4 2017 | $244,000 | +68.3% | 37,615 | +60.9% | 1.53% | +478.5% |
| Q3 2017 | $145,000 | +163.6% | 23,375 | +81.6% | 0.26% | +154.8% |
| Q2 2017 | $55,000 | -5.2% | 12,875 | 0.0% | 0.10% | -11.1% |
| Q1 2017 | $58,000 | -57.4% | 12,875 | -48.2% | 0.12% | -59.4% |
| Q4 2016 | $136,000 | -100.0% | 24,875 | -44.6% | 0.29% | -28.4% |
| Q3 2016 | $287,360,000 | +322776.4% | 44,900 | +128.8% | 0.40% | +450.7% |
| Q2 2016 | $89,000 | -99.8% | 19,625 | +31.6% | 0.07% | +97.3% |
| Q1 2016 | $58,447,000 | +70318.1% | 14,910 | 0.0% | 0.04% | -26.0% |
| Q4 2015 | $83,000 | -13.5% | 14,910 | -2.4% | 0.05% | -26.5% |
| Q3 2015 | $96,000 | – | 15,280 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |